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In a penciling­induced epilepsy model, Wistar rats (16 males, 16 females) were i.p. 
administered by an extract of Salvia miltiorrhiza (SmE; total dose 50mg/kg) once a day, 
during 15 days. The rats were divided into four equal groups, control and SmE­treated for 
each sex. After the treatment period, an epilepsy model was produced by penicillin G (500 IU) 
injection into the motor cortex; the electrocorticogram (EcoG) was recorded for 120 min, and 
statistical analysis was performed. In the male control group with penicillin­induced epilepsy, 
the spike frequency was significantly (P < 0.05) higher than that in the female control group. The 
frequency values have been significantly (P < 0.01) increased within the observation period in the 
female SmE­treated group, while the respective values significantly (P < 0.05) decreased in the 
analogous male group. There were insignificant differences in the amplitude values and latency 
to onset of the spike/wave events between female/male SmE and female/male control groups (P > 
> 0.05). Thus, the SmE exerts anticonvulsant effects in the male rat group, while its effect should 
be characterized as proconvulsant in the female group in penicillin­induced epilepsy model. The 
difference (related to the presence of estrogen analogs in the SmE) is determined by dissimilar hor­
monal backgrounds in males and females. The SmE may be considered the base for development of 
anticonvulsant drugs for clinical therapy of epilepsy in the future. 
Keywords: Salvia miltiorrhiza, electrocorticography, penicillin-induced epileptiform 
activity, rats.
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Epilepsy is one of the most serious neurological 
disorders, and the disease is observed at a high 
incidence in the world [1, 2�. A number of studies have 
been devoted to the pathogenesis of epilepsy. Epilepsy 
is determined by abnormally excessive and/or higher­
synchronized neuronal activity in the brain. The 
mechanism underlying these events can be determined 
as excessive excitation and/or insufficient inhibition 
in the brain areas where the abnormal discharges start. 
Thus, the uncontrolled and abnormally synchronized 
electrical discharges can occur as a result of 
increased glutamate release (which is an excitatory 
neurotransmitter) and/or decreased GABA release 
(which is an inhibitory neurotransmitter) in one or 
more brain areas [3�. Epileptic seizures are transient 
events accompanied by the epilepsy symptoms. In 
many reports, it was shown that there are considerable 
sex differences in the sensitivity to diverse convulsants 
in animal models [4–7�.
Different experimental studies in animal models 
play an important role in the research of the epilepsy 
pathogenesis; epileptic seizures are mimicked in these 
models [8,9�. A penicillin­induced experimental model 
of epilepsy has been frequently utilized by various 
researchers. Penicillin applications cause acute focal 
epileptic activity similar to the epileptic activity 
related to the above­mentioned imbalance between 
inhibitory and excitatory neurotransmitters [10–13�.
A Salvia miltiorrhiza extract (SmE) contains 
considerable amounts of acetylcholinesterase (AChE) 
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and butyrylcholinesterase (BChE); this extract is a 
promising mean in the treatment of various disorders 
of the CNS. As was shown, this extract positively 
influences memory and other cognitive activities 
[14­16�. The SmE has been used as an antihydrotic, 
spasmolytic, antiseptic, and anti­inflammatory mean 
in the treatment of mental and neurological disorders 
[16, 17�. Some authors reported on its antioxidant 
properties, which is essential for scavenging free 
radicals (due to the presence of phenolic compounds 
such as carnosic, rosmarinic, caffeic, salvianolic 
acids, and other phenolic structure­based compounds) 
[18­22�. Various types of this extract demonstrated 
antibacterial, cytotoxic, and antiviral effects [23�. 
Additionally, SmE showed a cardioprotective effect 
(against ischemic injuries); an important property 
of this extract is that it provides vasodilation in the 
coronary arteries [24�. Furthermore, as was found 
in several studies, SmE contains estrogen­derived 
compounds. As was shown, estrogens reduce seizure­
induced cell death, whereas these compounds can 
facilitate the onset of seizures [16, 25, 26�.
According to our knowledge, the effects of SmE 
on epileptiform activities have not been investigated; 
this, in particular, is related to the sex differences in 
an experimental penicillin­induced rat epilepsy model. 
We tried to evaluate the effects of this mean on the 
model of epileptic activity in the groups in both female 
and male rats. 
METHODS 
Animals, Experimental Procedure, and SmE 
Extract Treatment. Thirty­two Wistar albino rats 
(aged 4­5 months, body mass 200­250 g) were used in 
the experiments. They were maintained at a 12 h light­
dark cycle, with free access to standard laboratory food 
and water. The rats were housed in metabolic cages 
at a temperature of 22 ± 2 °C and relative humidity 
of 50­60%; their body temperature was maintained 
around 37 ± 0.5 °C during the study. The rats were 
separated into the following four groups, 8 animals 
in each group: group 1, female control group treated 
with physiological (0.9%) saline (0.5 ml, i.p); group 2, 
female SmE­treated group (SmE, 50 mg/kg, i.p); group 3, 
male control group treated with physiological saline 
(0.5 ml, i.p), and group 4, male SmE­treated group 
(SmE, 50 mg/kg, i.p).
The SmE was supplied by the University of Abant 
Izzet Baysal, (Dept. of Biology). The ethanolic SmE 
was prepared according to the technology described by 
Eidi et al. [27�. Treated groups received i.p injections 
of the extract once a day during 15 days up to the 
50 mg/kg total dose.
Penilicin G-Induced Epilepsy Model and 
Electrocorticography. After 15­day­long treatment 
with SmE or saline, all rats were weighed, anesthetized 
with 1.20 g/kg urethane (Sigma Aldrich, USA, i.p), 
and immobilized in a streotaxic apparatus (Harvard 
Apparatus, USA). The scalp was incised rostro­
caudally approximately 2­4 cm in length, and a hole 
(2 mm in diameter) was drilled 1.5 mm left from 
the bregma; the bone particles and dura mater were 
carefully removed.
The left cerebral cortex was exposed. Then, two 
Ag­AgCl ball electrodes were placed over the left 
motor cortex (2 mm lateral to the sagittal suture, 
1 mm anterior, and 5 mm posterior to the bregma). 
The common reference electrode was fixed on the left 
pinna. The ECoG signals were amplified and filtered 
(0.1­50 Hz bandpass) using BioAmp amplifiers (AD 
Instruments, Australia) and digitized at a sampling 
rate of 1024 sec–1 using a four­channel data acquisition 
system (PowerLab 8/SP; AD Instruments, Australia). 
The baseline activity in each group was recorded 
within initial five minutes. 
An epileptiform activity was induced by intracortical 
injection of 2.5 ml penicillin G (500 IU, Merck, USA) 
in all rats. Using a Hamilton injector (type 701 N; 
USA), penicillin was injected into the left sensorimotor 
cortex (2 mm posterior to the bregma, 3 mm lateral 
to the sagittal suture, and 2 mm ventral to the brain 
surface) at an infusion rate of 0.5ml/min. The ECoG 
activity was continuously recorded during 120 min, 
displayed, and stored using a computer. The frequency 
(sec–1) and amplitude (mV) values of spike/wave 
complexes and the latency (min) of onset of the first 
spike/wave event for each animal were automatically 
measured using a data acquisition Chart v.5.1.1 system 
(PowerLab software; AD Instruments, Australia) and 
analyzed offline. 
Statistical Analysis.  The frequency (sec–1), 
amplitude (mV) values for spike/wave complexes 
and the latency (min) to onset of the first spike/wave 
activity were gathered from animals in all groups and 
converted to a scaling percentage in a time­dependent 
manner. All statistical procedures were performed 
using Statistical Package for the Social Science 
(SPSS) version 15.0 (SPSS Inc., USA). Numerical data 
are expressed below as means ± s.d. The data were 
analyzed by one­way analysis of variance (ANOVA) 
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followed by the least significant difference (LSD) 
post hoc test for multiple comparisons. Statistical 
significance was accepted at P < 0.05.
RESULTS 
Effects of SmE on Penicillin G-Induced Epileptiform 
Activity. Penicillin­induced epileptiform discharges 
were characterized by bilateral spikes and spike/
wave complexes generated against the background 
ECoG activity. Epileptic activity reached a constant 
level in 30 min after the administration of penicillin G 
and lasted for 3­5 h. The SmE was last time injected 
30 min after injection of penicillin (Fig. 1). 
As was mentioned above, the frequency and 
amplitude of spike/waves and the latency to onset 
of the fist spike/wave were calculated from the 
SmE-freated 
males
Control 
males
Control 
females
Basal 
activity
0.5 mV
5 sec
SmE-treated 
females
F i g. 1. Changes in ECoG activity after administration of penicillin 
G in the SmE­treated and control animals.
Р и с. 1. Зміни ЕКоГ­активності після введення пеніциліну G у 
контрольних тварин та тих, котрим уводили SmE.
T a b l e 1. Spike-wave frequency (Hz) in the control and Salvia extract-treated groups
Т а б л и ц я 1.  Середні значення частоти в комплексах пік–хвиля у контрольних тварин та тих, яким уводили екстракт 
шавлії
Time, 
min 
Female control (n= 8) Female SmE group (n = 8) Male control  (n = 8) Male SmE 
group (n = 8)
5 0.0 ± 0.0 0.0 ± 0.0 0.0 ± 0.0 0.0 ± 0.0
10 0.0 ± 0.0a 174.0 ± 35.0a 5.0 ± 4.5b 84.8 ± 21.8b
15 52.5 ± 8.9a 200.8 ± 22.2a 52.4 ± 31.0c 129.8 ± 28.3c
20 144.2 ± 11.9 191.0 ± 24.3 99.3 ± 34.7 160.7 ± 19.5
25 159.6 ± 16.8 188.8 ± 27.9 123.8  ± 35.2 160.8 ± 11.0
30 148.9 ± 14.6 180.0 ± 26.3 129.2 ± 28.2 166.8 ± 10.0
35 147.3 ± 13.3 184.6 ± 20,9 140.7 ± 27.2 153.4 ± 7.1
40 141.5 ± 9.6 180.0 ± 13.6 211.8 ± 45.5 158.0 ± 17.3
45 129.7 ± 8.9 174.6 ± 16.6 166.7 ± 35.6 148.5 ± 17.5
50 128.0 ± 10.4 164.3 ± 17.2 292.4 ± 71.3d 154.2 ± 17.8
55 124.0 ± 12.6 144.6 ± 15.0 258.8 ± 27.2e 138.5 ± 20.9
60 132.5 ± 23.1 158.8 ± 21.8 288.8 ± 28.1e 144.8 ± 19.4
65 114.2 ± 15.3 111.0 ± 23.1 299.3 ± 31.4e 139.7 ± 18.6
70 108.7 ± 14.8 132.5 ± 14.5 307.3 ± 33.5e 138.7 ± 18.2
75 109.8 ± 10.8 148.3 ± 26.9 270.6 ± 37.4e 123.5 ± 22.6
80 118.2 ± 14.9 147.5 ± 26.7 290.3 ± 42.5e 129.1 ± 20.2
85 114.0 ± 19.1 145.5 ± 26.2 282.7 ± 45.0e 121.1 ± 16.3
90 113.3 ± 28.4 141.8 ± 23.5 278.2 ± 44.3e 126.2 ± 20.9
95 117.7 ± 34.7 139.6 ± 26.1 272.2 ± 45.4f 120.4 ± 19.8
100 114.7 ± 33.0 137.3 ± 29.7 264.8 ± 47.0f 121.1 ± 18.4
105 103.7 ± 27.8 130.5 ± 32.0 240.0 ± 49.8f 104.0 ± 19.0
110 91.8 ± 23.5 140.1 ± 40.9 212.6 ± 45.6g 106.1 ± 18.9
115 84.3 ± 22.3 119.3 ± 30.6 193.1 ± 44.8 g 100.7 ± 18.0
120 85.3 ± 20.4 101.0 ± 20.9 203.5 ± 45.3e 96.1 ± 13.3
All values are shown as means ± s.d. for each group; n is the number of examined rats. Comparisons: (a) female control vs female 
SmE group (P < 0.01); (b) male control vs male SmE (P < 0.01); (c) male control vs male SmE (P < 0.05); (d) male control vs other 
groups (P < 0.05); (e) male control vs other groups (P < 0.01); (f) male control vs female control and male SmE groups (P < 0.01); (g) 
male control vs female control and male SmE groups (P < 0.05).
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index in the female control group within nearly entire 
period of observation. At the same time, the spike/
wave frequency in the male SmE­treated group was 
significantly (P < 0.01) lower than that in the male 
control group at most examined time intervals. Finally, 
the spike/wave frequency was significantly (P < 0.01) 
greater in the female SmE­treated group as compared 
with the value that has been significantly (P < 0.05) 
decreased in the male SmE­treated group (Fig. 2, Table 
1). In other words, SmE exerted an anticonvulsant 
effect in the male group, while the proconvulsant effect 
was observed in the female group in the penicillin 
G­induced epilepsy model.
When we evaluated the effect of SmE on the spike/
wave amplitude values (mV), we found no significant 
differences among all groups at most time intervals of 
observation (P > 0.05), although this amplitude in the 
male control group was higher significantly (P < 0.05) 
than that in the female control group at the 20th min of 
the period of recording (Table 2, Fig. 3). 
When we also evaluated the effect of SmE (according 
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F i g. 2. Values of the spike/wave frequency (Hz) in the control and 
SmE­treated groups.
Р и с. 2.  Динаміка частоти комплексів пік–хвиля в контрольних 
групах та групах, котрим уводили SmE.
T a b l e 2. Amplitudes of the spike-wave complexes (mV) in the control and SmE-treated groups
Т а б л и ц я 2.   Середні значення амплітуд комплексів пік–хвиля у контрольних тварин та тих, яким уводили екстракт 
шавлії
Time (minutes) Female control (n = 8) Male control (n = 8) Female SmE group 
(n = 8)
Male SmE group
 (n = 8)
5 0.40 ± 0.1 1.21 ± 0.7 0.72 ± 0.1 0.76 ± 0.1
10 0.40 ± 0.1 1.25 ± 0.8 1.65 ± 0.3 1.05 ± 0.2
15 0.40 ± 0.1 1.86 ± 0.9 2.01 ± 0.4 1.50 ± 0.2
20 0.33 ± 0.1a 2.48 ± 1.1a 2.18 ± 0.4 1.63 ± 0.2
25 1.85 ± 0.2 2.42 ± 1.0 2.30 ± 0.4 1.80 ± 0.3
30 2.55 ± 0.3 2.72 ± 1.1 2.17 ± 0.3 1.82 ± 0.3
35 2.96 ± 0.4 2.76 ± 1.0 2.33 ± 0.5 1.88 ± 0.3
40 3.10 ± 0.4 3.08 ± 1.0 2.21 ± 0.4 1.93 ± 0.3
45 3.27 ± 0.5 3.02 ± 1.0 2.40 ± 0.5 1.98 ± 0.3
50 3.26 ± 0.5 3.25 ± 1.0 2.27 ± 0.4 2.00 ± 0.3
55 3.25 ± 0.5 3.23 ± 0.9 2.26 ± 0.4 2.00 ± 0.3
60 3.17 ± 0.5 3.40 ± 1.0 2.31 ± 0.4 2.07 ± 0.3
65 3.19 ± 0.5 3.36 ± 0.9 1.84 ± 0.2 1.83 ± 0.3
70 3.03 ± 0.5 3.34 ± 0.9 1.77 ± 0.2 1.89 ± 0.3
75 2.93 ± 0.5 3.00 ± 0.9 1.82 ± 0.3 1.99 ± 0.3
80 2.92 ± 0.4 3.11 ± 0.9 1.84 ± 0.3 1.96 ± 0.3
85 2.79 ± 0.4 3.00 ± 0.9 1.92 ± 0.3 1.97 ± 0.3
90 2.83 ± 0.4 3.03 ± 0.9 1.79 ± 0.3 2.00 ± 0.3
95 2.64 ± 0.4 2.87 ± 0.9 1.94 ± 0.4 2.00 ± 0.3
100 2.55 ± 0.5 2.82 ± 0.9 1.92 ± 0.4 1.98 ± 0.2
105 2.70 ± 0.5 2.91 ± 0.9 1.86 ± 0.5 1.89 ± 0.3
110 2.69 ± 0.5 2.96 ± 0.9 1.98 ± 0.5 1.95 ± 0.3
115 2.61 ± 0.5 2.87 ± 0.9 1.60 ± 0.4 1.94 ± 0.3
120 2.58 ± 0.5 2.80 ± 0.8 1.66 ± 0.4 1.90 ± 0.3
(a) Comparision of the female control  vs male control group (P < 0.05). Other designations are similar to those in Table 1.
recorded ECoGs. In the male control group, the 
spike/wave frequency was significantly (P < 0.05) 
higher than that in the female control group. In the 
female SmE­treated group, the spike/wave frequency 
significantly (P < 0.01) exceeded the respective 
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to the sex groups) on the latency (sec) to onset of the 
first spike/wave event, there was an insignificant 
difference (P > 0.05) between the mean value of this 
index in the female SmE group (288.50 ± 46.15 sec) 
and female control group (246.25 ± 98.27 sec). 
In the male groups, there was also no significant 
difference (P > 0.05), while the value in the male 
SmE group (635. 42 ± 344.21 sec) was smaller than 
in the male control group (757. 5 ± 461.36 sec). 
However, the spike/wave latency in the SmE­treated 
group (635.42 ± 344.21 sec) was significantly longer 
(P < 0.05) than this time index in the female SmE group 
(288.50 ± 46.15 sec) of rats. The analogous difference 
between the latencies to onset of the first spike/wave 
was observed in the control groups (757.5 ± 461.36 
sec vs 246.25 ± 98.27 sec in females; P < 0.01).
differences in the sensitivity to various convulsants 
was demonstrated in animal models of epilepsy [4­7�.
Previous studies suggested that chemoconvulsants 
act on the GABA receptor complexes, and binding 
sites for different convulsants are dissimilar. Sex­ and 
species­related differences for such GABA­related 
convulsants as bicuculline and picrotoxin were found 
in animal experiments [5, 28­30�. Sex and levels of 
sexual hormones affect the incidence and severity of 
seizures [26, 31, 32�. In animal models of different 
experimental epileptiform states, the effects of 
testosterone, progestrone, and estrogen were shown 
to be considerably different [26�. For example, 
progestrone exerts an anticonvulsant effect in females, 
while in males the effect should be characterized as 
proconvulsant [33�. Testosterone has a proconvulsant 
effect in females, while testosterone exerts an 
anticonvulsant action in males in experimental 
animal studies [34­36�. However, it was reported in 
some communications that the effects of estrogen are 
excitatory, while those of progesterone are inhibitory 
[37­40�.
At present, pharmacological therapies use various 
anticonvulsant medications, but most these therapies 
remain insufficient to prevent epileptic seizures 
completely. Naturally, it is necessary to search for 
new more effective and safer therapeutic agents. Some 
studies have shown that Salvia miltiorrhiza contains 
important substances effective in CNS disorders. 
The extract of this plant provides positive effects on 
memory and other cognitive activities [14­16�. In 
many works, it was demonstrated that SmE can be 
used as an antihydrotic, spasmolytic, antiseptic, and 
anti­inflammatory mean in the treatment of mental 
and nervous disorders [16, 17�. Our study is, probably, 
the first where the effects of SmE on the penicillin 
G­induced experimental epilepsy model in rats have 
been examined. It was found that estrogen reduces 
seizure­induced cell death, while it facilities the onset 
of seizures [16, 25, 26�. Considering that SmE contains 
estrogen­derived compounds, we investigated the pro­ 
vs. antiepileptic properties of this mean between the 
groups of female and male rats in the penicillin model 
of epilepsy. 
In our study, focal epilepsy was produced in rats 
by penicillin G administration into the sensorimotor 
cortex. We measured the frequency of generation 
and amplitude values of spike/wave complexes and 
latencies of their onset in ECoG in SmE­treated and 
control animals. Our results indicated that the spike/
wave frequency increased in the female SmE­treated 
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F i g. 3. Values of the amplitude of the spike/wave complexes (mV) 
in the control and SmE­treated groups.
Р и с. 3. Динаміка амплітуди комплексів пік–хвиля в контрольних 
групах та групах, котрим уводили SmE.
DISCUSSION
Epilepsy is a common chronic neurologic disorder 
characterized by spontaneous recurrent seizure 
events in various cerebral regions [1, 2�. So far, 
many researchers tried to discover the pathogenetic 
mechanism of epilepsy, but this problem has not 
been finally resolved. In general, the development 
of epilepsy is based on excessive excitation and/
or excessive inhibition in one or another brain 
area, and this situation results in uncontrolled and 
abnormally synchronized electrical discharges in the 
brain neuronal networks. Increased glutamate and/or 
decreased GABA releases probably cause these events 
[3�. In many studies, the existence of sex­related 
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group, while this value decreased in the analogous 
male group. In addition, we found under conditions 
of the penicillin G­induced epilepsy model that the 
spike/wave frequency in the male control group was 
higher than that in the female control group (Table 1, 
Fig. 2). In conclusion, these results suggest that SmE 
provides a considerable anticonvulsant effect in the 
male group, while the effects should be characterized 
as proconvulsant in the female group. Thus, the effect 
of SmE treatment on penicillin G­induced epileptiform 
activity is clearly sex­specific. 
When we evaluated the effect of SmE on the spike/
wave amplitude, we found no significant difference 
among all groups within most time periods (P > 0.05), 
although the amplitude value in the male control 
group was higher significantly (P < 0.05) than that 
in the female control group at the first 20th min of 
recording of the activity (Table 2, Fig. 3). As to the 
latency to onset of the first spike/wave, there were 
no significant differences (P > 0.05) between the 
female SmE group and female control group. In the 
male groups, there was also no statistical difference 
(P > 0.05). On the other hand, i.p injections of 
SmE in male rats significantly increased (P < 0.05) 
the respective values, as compared with the female 
SmE group. The mean latency to onset of the first 
spike/wave complex in the male control group was 
significantly (P < 0.01) longer than that in the female 
control group. 
These data indicate that SmE extract exposure 
has not been generated any effect on the latency to 
onset of the first spike/wave between the female or 
male SmE­treated groups. However, rat females 
demonstrated increased sensitivity of epileptiform 
activity on account of the latency to onset of the 
first spike/wave. In both male SmE­treated and male 
control groups, the latency to onset of the first spike/
wave was significantly longer than that in the female 
SmE­treated and control groups. 
We propose that the anticonvulsant activity of 
SmE extract could be attributed to the interaction of 
active compounds (such as flavonoid derivatives) with 
benzodiazepine (BDZ) sites of GABAA receptors in 
brain tissue. Active structural components that bind 
to the chloride channels of the GABAA/BDZ receptor 
complex may be considered active inhibitory agents 
influencing the CNS. This is why the GABAA/BDZ 
receptor system should be significantly involved in 
the formation of the antieplieptic effects of SmE. A 
methanolic extract of Salvia was shown to exert a 
strong inhibitory effect on adenylate cylase (AC) in 
the rat somatomotor cortex. However, we could not 
explain the mechanism by which the SmE provides 
proconvulsant effects in the female group. We did 
not examine the relationship between the effect of 
SmE and the hormone levels, such as the estradiol 
(E2) prostaglandin alpha (PGFα) contents in the rat 
plasma, as well as interrelations of these indices with 
epileptiform activity. Other SmE­induced effects, 
such as changes in the index of cell death in different 
experimental groups, and increased expression of 
ATP­dependent potassium channel (K­ATP) proteins 
related to an estrogen effect, should be examined, and 
the respective results may help ones to interpret the 
mechanisms of  anti­ and proconvulsant effects of 
SmE in the above­mentioned groups treated with this 
extract. 
In conclusion, our results support the hypothesis 
that the extract of Salvia miltiorrhiza (SmE) may be 
used in the future as a base for potential anticonvulsant 
drugs for clinical therapy of epilepsy. Further studies 
on structure­activity relationship between the 
components of the SmE are needed in order to explain 
the mechanisms of modulation of epileptiform activity 
manifested by this drug. The same can be told on the 
dose­dependence of the SmE effects and specificity of 
these effects with respect to sex groups. 
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Р е з ю м е
В умовах моделювання епілептичної активності (індукція 
інтракортикальним уведенням пеніциліну) щурам лінії 
Вістар (16 самців і 16 самиць) уводили екстракт шавлії (Sal­
via miltiorrhiza extract, SmE, загальна доза 50 мг/кг, щоденні 
ін’єкції протягом 15 діб). Щури були поділені на чотири 
рівні групи  – контрольні та піддані ін’єкціям SmE самці 
та самиці. Після періоду введень екстракту епілептиформна 
активність індукувалась уведенням (500 МО) пеніциліну G 
у моторну кору, після чого відводили електрокортикограму 
(EКoГ) протягом 120 хв та піддавали її статистичному 
аналізу. В контрольній групі самців частота в ЕКоГ­
комплексах пік–хвиля була вірогідно вищою (P < 0.05), ніж 
така в контрольній групі самиць. Значення частоти істотно 
зростали (P < 0.01) у групі самиць котрим уводили SmE, 
тоді як відповідні значення в аналогічній групі самців 
вірогідно зменшувалися (P < 0.05). Не було виявлено 
істотних відмінностей між середніми значеннями амплітуд 
комплексів пік–хвиля та латентних періодів виникнення 
таких комплексів у групах самиць та самців, котрим уводили 
SmE, та аналогічних контрольних груп самиць і самців 
(P > 0.05). Отже, SmE проявляє протисудомні впливи в 
умовах пеніцилінової моделі епілепсії в групі самців­
щурів, тоді як у групі самиць ефекти мають кваліфікуватись 
як просудомні. Різниця в характері впливів, зумовлена 
наявністю аналогів естрогенів у SmE, визначається 
різним гормональним фоном у самиць і самців. SmE може 
розглядатись як основа для розробки антиконвульсантних 
засобів для терапії епілепсії  в майбутньому.
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